When a diverse group of patients were invited to take a genetic risk test for common, preventable diseases, only 7% accepted.
This light-activation technology has potential applications in tissue engineering, regenerative medicine, and understanding how the body works.
Findings suggest a largely overlooked cellular signaling system may play a more important role in bacteria than previously thought.
A team led by the Institute for Protein Design devised machine-learning algorithms that created light-emitting enzymes called luciferases.
Collaboration finds that improved training and support of community health workers are needed to improve HIV testing.
Analysis of the outbreak shed light on its origins and transmission patterns, and assessed treatment and infection control.
Study reveals new therapeutic target to subdue autoimmune inflammation caused by loss of regulatory T cell function.
Treatment of childhood-onset hearing loss can be more precisely tailored with information on specific genetic cause.
Harnessing light energy to rejuvenate mitochondrial membrane potential slowed aging in C. elegans.
Most Alzheimer’s drugs in development target beta-amyloid, but targeting another protein, called tau, may be needed.
Latest work unexpectedly shows two close bat virus relatives of human respiratory virus MERS-CoV use bat ACE2 as cell entry receptor.
Results from a new molecular study provide a framework to guide engineering of future SARS-CoV-2 vaccines.
Study findings suggest that a vaccine could be used to prevent or treat a particularly aggressive form of breast cancer.
Omnipose is trained to recognize bacteria of all shapes and sizes in mixed bacterial cultures.
Understanding antibody responses will be key to offset coronavirus variants' evasion of earlier immunity.
Papers in Science show how machine learning can accelerate solutions for protein design challenges.
Encouraging immune-response and safety data emerge from preliminary human test of a genetically attenuated parasite vaccine.
Genetically modified mouse studies reveal pathways for organ-damaging autoimmune response.